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Introduction
Neuronal apoptosis is induced by numerous stressors and 
  underlies many human neurodegenerative disorders, such as 
Alzheimer’s and Parkinson’s disease. Under such apoptotic 
conditions, several neurotrophic factors such as glial cell line–
derived neurotrophic factor (GDNF) and brain-derived neuro-
trophic factor (BDNF) can activate the antiapoptotic process 
to rescue neurons from death. However, the signaling pathway 
leading to cell survival is not yet completely understood. GDNF 
was reported to exert a potent survival-promoting activity 
in neurons (Henderson et al., 1994; Oppenheim et al., 1995; Yan 
et al., 1995) and to reduce neuronal death induced by various 
toxic challenges both in vitro (Nicole et al., 2001) and in vivo 
(Wang et al., 2002; Kirik et al., 2004). Recent evidence suggests 
that a part of molecular mechanisms for GDNF-induced cell 
survival relates to an increase in intracellular Ca
2+ concentra-
tion, and it subsequently activates some survival pathways such 
as the phosphatidylinositol 3-kinase (PI3-K)–Akt pathway 
(Perez-Garcia et al., 2004).
Ca
2+ is the most versatile and important intracellular 
  messenger in neurons, regulating a variety of neuronal pro-
cesses such as neurotransmission and signal transductions. 
The various actions of Ca
2+ are mediated by a large family of 
EF-hand Ca
2+-binding proteins, which may act as Ca
2+ sensors 
or Ca
2+ buffers. One of them, neuronal Ca
2+ sensor-1 (NCS-1; 
mammalian   homologue of frequenin), was originally identifi  ed 
in   Drosophila melanogaster in a screen for neuronal hyperexcit-
ability mutants (Mallart et al., 1991). Overexpression of NCS-1 
has been shown to enhance evoked neurotransmitter release and 
exocytosis (Pongs et al., 1993; Olafsson et al., 1995). NCS-1 
directly   interacts with phosphatidylinositol 4-hydroxykinase 
(PI4-K;   Hendricks et al., 1999; Weisz et al., 2000) and enhances 
neu  ronal secretion by modulating vesicular traffi  cking steps in 
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A
molecular basis of survival from neuronal 
injury is essential for the development of thera-
peutic strategy to remedy neurodegenerative 
disorders. In this study, we demonstrate that an EF-hand 
Ca
2+-binding protein neuronal Ca
2+ sensor-1 (NCS-1), 
one of the key proteins for various neuronal functions, 
also acts as an important survival factor. Overexpres-
sion of NCS-1 rendered cultured neurons more tolerant 
to cell death caused by several kinds of stressors, 
whereas the dominant-negative mutant (E120Q) accel-
erated it. In addition, NCS-1 proteins increased upon 
treatment with glial cell line–derived neurotrophic factor 
(GDNF) and mediated GDNF survival signal in an 
Akt (but not MAPK)-dependent manner. Furthermore, 
NCS-1 is signiﬁ   cantly up-regulated in response to 
  axotomy-induced injury in the dorsal motor nucleus of 
the vagus neurons of adult rats in vivo, and adenoviral 
overexpression of E120Q resulted in a signiﬁ  cant loss 
of surviving neurons, suggesting that NCS-1 is involved 
in an antiapoptotic mechanism in adult motor neurons. 
We propose that NCS-1 is a novel survival-promoting 
factor up-regulated in injured neurons that mediates 
the GDNF survival signal via the phosphatidylinositol 
3-  kinase–Akt pathway.
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a phosphoinositide-dependent manner (Koizumi et al., 2002). 
We have previously demonstrated that NCS-1 modulates the 
 voltage-gated  K
+ channel Kv4 (Nakamura et al., 2001). Sub-
sequently, certain voltage-gated Ca
2+ channels have also been 
reported to be regulated by NCS-1 (Weiss et al., 2000; Wang 
et al., 2001; Tsujimoto et al., 2002). Furthermore, NCS-1 
  enhances the number of functional synapses (Chen et al., 
2001), potentiates paired pulse facilitation (Sippy et al., 2003), 
and may be involved in associative learning and memory in 
Caenorhabditis elegans (Gomez et al., 2001). Despite the 
  participation of NCS-1 in a wide range of biological functions, 
however, the role of NCS-1 in neuronal survival under pat  ho-
physiological conditions or the involvement of NCS-1 in 
  neurotrophic factor–mediated neuroprotection are unknown.
Because we found that the expression levels of NCS-1 is 
signifi  cantly higher in immature brain (Nakamura et al., 2003) 
and a remarkable similarity exists between immature and 
  injured neurons during the development and regeneration 
  process, respectively (Nabekura et al., 2002b), these fi  ndings 
prompted us to study the expression level and the functional 
roles of NCS-1 in damaged neurons.
In this study, we found that NCS-1 is a survival- promoting 
factor, which increases the resistance of neurons to several 
kinds of stressors. In addition, NCS-1 is up-regulated in 
  response to axonal injury in adult motor neurons, and this 
  protects cells from apoptosis. Furthermore, NCS-1 mediates 
GDNF-induced neuroprotection via activation of Akt pathways. 
This is the fi  rst study demonstrating a novel role of NCS-1 on 
neuronal survival.
Results
The expression level of NCS-1 protein 
increases with neuronal injury
To examine the expression level of NCS-1 in injured neurons, 
we performed unilateral vagal axotomy (transaction of nerves) 
on adult rats. 1 d to 2 mo after the in vivo axotomy, brain-
stems, including the bilateral dorsal motor nucleus of the 
  vagus (DMV) neurons, were isolated. Immunohistochemical 
  staining and computerized image analysis of frozen sections 
  revealed that axotomy signifi   cantly (more than threefold) 
  increased the expression level of NCS-1 in the DMV when 
compared with those on the control side at 1 wk after the 
  surgery (Fig. 1, A–C). NCS-1 immunoreactivity was mainly 
  expressed in cell bodies of neurons, as shown using hematox-
ylin counterstaining to identify the nuclei (Fig. 1 B, brown 
staining accompanied with blue staining; depicted by arrows). 
The increase in NCS-1 level started at 1 d after axotomy, 
reached a peak at 1 wk, and gradually decreased to control 
levels over the next 2 mo (Fig. 1 D). We also conducted quan-
titative immunoblot analysis on tissue samples from DMV 
neurons 1 d and 1 wk after axotomy, expressing NCS-1  density 
relative to levels of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). The results confi  rmed the immunohistochemistry 
experiments, with levels of NCS-1 protein in ipsilateral DMV 
being increased signifi  cantly (by about threefold) by 1 wk 
  after axotomy (Fig. 1, E and F).
Up-regulation of NCS-1 protein was also observed using 
a different type of stressor. Continuous treatment of neurons 
with colchicine for 4 d, which disrupts tubulin polymerization 
and blocks axonal transport, also increased NCS-1 expression 
levels (1.40 ± 0.03-fold above control levels; P < 0.05; n = 4), 
indicating that NCS-1 is up-regulated in vivo in response to two 
Figure 1.  NCS-1 is up-regulated in the DMV neurons after in vivo   axotomy. 
The 10th cranial nerve on one side of the neck of adult (4–6-wk-old) rats 
was cut, and, 1 d to 2 mo later, the brainstem was excised and frozen 
sections were cut. The NCS-1 expression was examined by counterstain-
ing with NCS-1 antibody (brown signal) and with hematoxylin to identify 
nuclei (blue signal). (A) Staining pattern 1 wk after in vivo axotomy. The 
amount of NCS-1 protein increased in the DMV neurons ipsilateral to 
axotomy (injured side) when compared with control neurons contralateral 
to axotomy. Positions of DMV neurons are represented by circles. (B) Mag-
niﬁ  ed image of DMV neurons. Arrows indicate that some neurons have 
both NCS-1 and hematoxylin staining, indicating that NCS-1 is expressed 
in cell bodies. Bars (A), 200 μm; (B) 50 μm. (C) Summarized data ob-
tained by computerized image analysis. The relative area stained using 
NCS-1 antibody on the injured side 1 wk after axotomy was normalized 
to that of the control side (means ± SEM [error bars]; n = 6). (D) Time 
course of the expression levels of NCS-1 in injured DMV neurons relative 
to uninjured DMV neurons. Immunohistochemical analysis of NCS-1 levels 
were performed in rats 1, 4, 7, 30, and 60 d after axotomy (means ± 
SEM; n = 6). (E) Immunoblots indicating the expression levels of NCS-1 in 
the tissue samples obtained from DMV regions in brainstem sections at 
control (C) and injured sites (I) 1 wk and 1 d after axotomy. 10 sections 
were used for each group. Similar amount of proteins were loaded on the 
gel as indicated by the similar amount of the internal control GAPDH. 
(F) The densities of NCS-1 bands were expressed relative to the density of 
GAPDH bands in each tissue sample, and the group data is summarized 
(means ± SEM; n = 3).ROLE OF NCS-1 AS A NEUROPROTECTIVE FACTOR • NAKAMURA ET AL. 1083
different kinds of stressors—one being mechanical and the 
other being chemical injury.
Expression of NCS-1 renders PC-12 cells 
more tolerant to stressors
To study the physiological role of NCS-1 in damaged neurons, 
we next examined the effect of NCS-1 overexpression on 
the susceptibility of cells to several kinds of stressors. PC-12 
cells stably transfected with either the NCS-1 expression vector 
(NCS-1/PC-12) or the vector alone (vector/PC-12) were differ-
entiated into neuronlike cells, and the resistance to H2O2 toxicity 
was compared between these two groups. As shown in the 
 immunofl   uorescent micrographs and immunoblot in Fig. 2 
(A, B, and G), the expression level of NCS-1 was found to 
be signifi  cantly higher in NCS-1/PC-12 cells compared with 
vector-transfected cells, although these cells also had some 
 endogenous  NCS-1.  [ID]FIG2[/ID]Treatment with a relatively high dose 
(300 μM) of H2O2 for 3 d in the absence of pyruvate resulted 
in   severe cellular damage in vector/PC-12 control cells; most 
cells were rounded up and detached from the substratum (Fig. 2 E). 
In contrast, the same treatment caused only a little damage to 
cells overexpressing NCS-1 (Fig. 2 F), indicating that the 
  expression of NCS-1 rendered PC-12 cells more tolerant to 
H2O2 toxicity. The expression of NCS-1 reduced cell death 
caused by treatment with up to 1,000 μM H2O2 (Fig. 2 H). 
The aforementioned results were obtained from three cell 
lines transfected with NCS-1 and with corresponding vector-
  transfected control. A similar benefi  cial effect of NCS-1 on cell 
  survival in response to 300 μM H2O2 was seen in two PC-12 
cell lines that were not treated with NGF (not depicted).
NCS-1 promotes the long-term survival 
of primary cultured cortical neurons under 
stress and normal conditions
To further confi   rm the involvement of NCS-1 in neuronal 
  survival, we overexpressed NCS-1 or its mutant E120Q in 
  primary cultured embryonic rat cortical neurons that express 
endogenous NCS-1. The E120Q mutant possesses an amino 
acid substitution within the third EF-hand Ca
2+-binding motif, 
which impairs Ca
2+ binding (Jeromin et al., 2004) but preserves 
the interaction with target proteins and, thereby, exerts a 
 dominant-negative effect by disrupting the function of endogenous 
NCS-1 (Weiss et al., 2000). We used an adenoviral transfer 
  system to transiently deliver the cDNA encoding NCS-1 
  together with EGFP (using an internal ribosome entry site–
  containing vector) and its E120Q mutant form into neurons 
  cultured for 5 d in neurobasal medium containing B27 trophic 
supplements. As indicated by cells with EGFP fl  uorescence and 
nuclei stained with Hoechst 33258, nearly 70% of neurons were 
successfully infected with each virus at 3 d after infection 
(Fig. 3 A). We examined the effects of overexpression of wild-
type and dominant-negative NCS-1 on neuronal survival under 
stress caused by B27 withdrawal, which has been reported to 
induce neuronal apoptosis (Brewer, 1995; Cheng et al., 2003). 
As shown in Fig. 3 B, B27 withdrawal promoted cell death in 
  vector-treated control neurons (left; also compare the vector 
groups with and without B27 in Fig. 3 D). Overexpression of 
NCS-1, on the other hand, signifi  cantly rescued cells from death 
(Fig. 3 B, middle). In contrast, the expression of E120Q resulted 
in more severe cell death accompanying bleb formation (Fig. 
3 B, right). To quantitatively analyze the time course for the 
changes in cell viability, the total number of surviving cells 
from the same fi   eld was counted daily by phase-contrast 
  microscopy   during 9 d (see Materials and methods). The results 
show that high cell viability was preserved upon expression of the 
wild-type NCS-1, whereas cell viability was reduced after the 
  expression of E120Q; i.e., the number of days required to reach 
70% cell viability were 5, 8, and 3 d for vector, NCS-1, and 
E120Q groups, respectively (Fig. 3 C). The expression levels of 
NCS-1 in each group of neurons before and after adenovirus 
  infection in the absence of B27 trophic supplements are shown 
in the   immunoblot (Fig. 3 E). Essentially the same results were 
  obtained by counting neurons with condensed nuclei using 
Figure 2.  Effects of the overexpression of NCS-1 on the susceptibility of 
PC-12 cells to H2O2 toxicity. PC-12 cells stably transfected with NCS-1 
(NCS-1/PC12) or vector alone (vector/PC-12) were differentiated into 
  neuronlike cells by treatment with 100 ng/ml NGF and exposed to several 
concentrations (0–1 mM) of H2O2. (A and B) Immunoﬂ  uorescent  micro-
graphs show that the expression level of NCS-1/PC12 cells is much higher 
than that in vector/PC12 cells. (C–F) Phase-contrast micrographs of PC-12 
cells exposed to 0 (C and D) or 300 μM H2O2 for 3 d (E and F). Bar, 40 μm. 
(G) Representative immunoblots showing expression levels of NCS-1 in 
  control vector and NCS-1–transfected cells. Also shown is the expression 
levels of the control protein GADPH obtained from immunoblots from the 
same cell samples. Unlike for NCS-1 levels, GADPH levels were not mark-
edly different in control and NCS-1–transfected cells. (H) Bar graph shows 
the cell viability evaluated by trypan blue exclusion assay (means ± SEM 
[error bars]; n = 8). *, P < 0.05 versus vector/PC-12 cells.JCB • VOLUME 172 • NUMBER 7 • 2006  1084
Hoechst staining (Fig. 3, F and G), thus reinforcing the 
 fi nding that the expression of NCS-1 protects neurons from 
cell death under apoptotic conditions. Furthermore, when 
B27 trophic supplement was kept in the culture medium 
(which is a less stress condition), the dominant-negative ef-
fect of E120Q was more clearly observed when compared 
with the vector control group (Fig. 3 D; also see A, where 
some blebs were observed in the neurons infected with 
E120Q mutant). In other preliminary experiments (not de-
picted), although the time course of the loss in cell viability 
was variable, overexpression of NCS-1 consistently delayed 
the loss of cell viability when B27 supplements were omit-
ted, and the expression of E120Q always increased the rate 
of cell death when B27 was present. These results suggest 
that endogenous NCS-1 is playing an important role in keep-
ing the long-term survival of cultured neurons under normal 
conditions in addition to the protective role from stress under 
apoptotic conditions.
Figure 3.  Survival-promoting effect of NCS-1 in primary cultured corti-
cal neurons. Neurons were infected with adenovirus carrying EGFP 
  vector alone, NCS-1, and its EF-hand mutant (E120Q) together with 
EGFP in the same internal ribosome entry site vector in culture medium 
containing neurobasal medium plus B27 trophic supplements, and they 
were further cultured in the presence or absence of B27 supplements 
(B27 supplements were withdrawn 2 d after the virus infections). (A) Fluor-
escent micrographs show the cultured neurons treated with adenovirus 
for 3 d (exhibiting strong EGFP signals) followed by treatment with a 
DNA-binding dye Hoechst 33258 to label their nuclei (red signals, 
pseudo-colored). (B) Phase-contrast micrographs show the cultured 
  neurons treated with adenovirus for 5 d in the absence of B27 trophic 
supplements. Bars, 40 μm. (C) Time course of cell viability for neurons 
infected with adenovirus in the absence of B27 trophic supplements. 
  Living neurons were counted daily by phase-contrast microscopy and 
plotted as a percentage of the initial number of neurons present on day 0 
(n = 4). The number of days required to reach 70% cell viability is 
shown by the dotted lines. (D) Summary of cell viability data obtained 
from neurons cultured in the absence and presence of B27 trophic 
  supplements at 5 d after virus infection. Error bars represent SEM. 
*, P < 0.05 versus the vector-controlled group. (E) Expression levels of 
NCS-1 and GAPDH in cultured neurons infected with each adenovirus 
indicated in the absence of B27 trophic supplements. (F and G) Staining 
patterns (light blue and white signals) of nuclei with Hoechst 33258 
(F) and normalized numbers of cells having condensed nuclei (G). 
The dark blue color was changed to light blue or white to visualize 
  signals more clearly. Bar, 15 μm.
Figure 4.  NCS-1 mediates GDNF-induced neuronal survival. (A) Primary 
cultured cortical neurons infected with adenovirus carrying vector 
alone (top), NCS-1 (middle), or E120Q mutant (bottom) were treated 
for 2 d with or without 10 ng/ml GDNF under the condition where B27 
trophic supplement was depleted. Bar, 40 μm. (B) Summary of cell 
  viability data. Viable cells were counted 2 d after GDNF treatment 
(+GDNF) or no treatment (control) and plotted as the percentage of the in-
itial number of neurons   present at day 0 in the same visual ﬁ  eld (mean ± 
SEM [error bars]; n = 4). All neurons, not just transfected cells, were 
  included in the cell viability counts. Note that treatment with E120Q 
largely prevented the GDNF-  induced neuronal survival effect. 
*, P < 0.05 versus the data without exposure to GDNF. (C) Expression 
levels of NCS-1 in cultured neurons treated with 10 ng/ml GNDF for the 
indicated times.ROLE OF NCS-1 AS A NEUROPROTECTIVE FACTOR • NAKAMURA ET AL. 1085
NCS-1 mediates GDNF-induced cell survival
A large body of evidence suggests that neuronal survival is 
promoted by neurotrophic factors such as BDNF and GDNF 
(Boyd and Gordon, 2003). Because the long-term applica-
tion of GDNF has been reported to enhance the expression of 
NCS-1 in Xenopus laevis motor neurons (Wang et al., 2001), 
we attempted to clarify the role of NCS-1 as a downstream 
mechanism of GDNF-induced cell survival in rat cortical 
neurons. When primary cultured cortical neurons were 
treated with 10 ng/ml GDNF for 2 d after the withdrawal of 
B27 supplements, neuronal survival was signifi  cantly   en-
hanced when compared with time-matched control (Fig. 4,
A [top] and B).  [ID]FIG4[/ID] Interestingly, the expression of NCS-1 
  mimicked the survival-promoting effects of GDNF; i.e., 
NCS-1 exerted a robust survival effect even in the absence 
of GDNF (Fig. 4, A [middle] and B). Most strikingly, the 
  expression of the dominant-negative NCS-1 mutant E120Q 
largely prevented cell survival induced by GDNF (Fig. 4, 
A [bottom] and B). Immunoblot analysis revealed that the 
application of 10 ng/ml GDNF resulted in a signifi  cant in-
crease in the expression level of endogenous NCS-1 within 
10 min, which further increased at 40 min in these neurons 
(Fig. 4 C). The amount of NCS-1 remained elevated through 
2 d of   exposure to GDNF (not depicted). These results show 
that the treatment of GDNF increases the expression level 
of NCS-1, which subsequently promotes neuronal survival, 
suggesting that GDNF-induced neuroprotection is at least in 
part mediated by NCS-1.
Figure 5.  NCS-1 promotes neuronal survival via activa-
tion of the PI3-K–Akt pathway. (A and B) Both NCS-1 
  expression and GDNF treatment increase the phosphory-
lation of Akt kinase. Primary cultured cortical neurons 
were treated with 10 ng/ml GDNF for the indicated time 
periods or were infected with adenovirus carrying vector, 
NCS-1, or E120Q mutant and further incubated for 7 d 
in the presence or absence of B27 trophic supplements. 
They were then subjected to immunoblot analysis to detect 
protein levels of total (Akt) and phosphorylated form 
(p-Akt, the mixture of anti–P-Ser-473 and anti–P-Thr-308 
antibodies, was used; A). The densities of phosphorylated 
Akt were normalized by those of total Akt levels and sum-
marized in the bar graph (B). *, P < 0.05 versus vector 
con  trol. (C and D) Both GDNF- and NCS-1–induced neu-
ronal survival were abolished by PI3-K inhibitor but not by 
MEK inhibitor. Primary cultured cortical neurons were in-
fected with adenovirus carrying NCS-1 or vector alone in 
medium lacking B27 trophic supplements. 3 d later, cul-
tures were treated with 20 μM LY294002 or PD98059. 
For the vector-treated group, some cultures were further 
treated with 10 ng/ml GDNF. (C) Adenovirus-infected via-
ble   neurons treated or untreated with GDNF for 3 d. Bar, 
40 μm. (D) Viable cells were counted and plotted as the 
percentage of the initial number of neurons present on 
day 0 (means ± SEM [error bars]; n = 4). *, P < 0.05 
versus the data with no inhibitors. (E and F) NCS-1 acti-
vates Akt kinase by increasing the plasma membrane 
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 levels in both CCL39 
cells (E) and cultured neurons (F). CCL39 cells and pri-
mary cultured rat cortical neurons were transiently trans-
fected with EGFP-Akt/PKB-PH together with either 
pCDNA3, NCS-1, or E120Q (1:3 ratios). 2 d later, cells 
were ﬁ  xed, and immunocytochemistry was performed to 
detect NCS-1 proteins. Both EGFP distribution (E, top; and 
F, green signals) and NCS-1 expression (E, bottom; and 
F, red signals) were visualized using a laser confocal micro  -
scope. Laser confocal sections through the middle of rep-
resentative cells in each treatment are shown. Arrows 
indicate the peripheral redistribution of the EGFP–PKB–PH 
in NCS-1–expressing cells. Bars, 10 μm.JCB • VOLUME 172 • NUMBER 7 • 2006  1086
Activation of the PI3-K–Akt pathway is 
involved in NCS-1–induced neuronal survival
In neurons, GDNF has been reported to promote cell survival 
via activation of signaling cascades involving the PI3-K–Akt 
pathway (Soler et al., 1999; Takahashi, 2001). In accordance 
with these studies, we also observed that exposure of primary 
cultured cortical neurons to GDNF resulted in a large increase 
in phospho-Akt levels (Fig. 5 A, left).  [ID]FIG5[/ID] Therefore, it was of 
interest for us to test whether NCS-1 also activates this kinase. 
We examined the effect of NCS-1 expression or its dominant-
negative form on Akt phosphorylation in the presence or 
  absence of B27 trophic supplements. When B27 trophic 
supplements were absent, the expression of NCS-1 signifi  cantly 
enhanced the phosphorylation of Akt, whereas expression 
of the dominant-negative mutant E120Q had little effect when 
compared with control vector-infected neurons (Fig. 5, A 
[middle] and B). On the other hand, when B27 supplements 
were present, a relatively high level of phosphorylated Akt 
was  observed in the vector-treated control group (Fig. 5, A [right] 
and B). Additional expression of exogenous NCS-1 further 
  increased the Akt phosphorylation level, whereas expression 
of the dominant-negative mutant suppressed phosphorylation 
(Fig. 5, A [right] and B). Thus, the phosphorylation levels of 
Akt in each group of neurons were well correlated with their 
viabilities, as shown in Fig. 3 D.
In addition, pretreatment of cultured cortical neurons 
with LY294002, an inhibitor of PI3-K, completely abolished 
both GDNF- and NCS-1–induced neuronal survival, whereas 
PD98059, an inhibitor of MAPK kinase (MEK), did not (Fig. 5, 
C and D). These results suggest that the NCS-1–induced 
  survival-promoting effect is mediated via the PI3-K–Akt path-
way but not the MAPK pathway in cultured cortical neurons.
To further understand the upstream mechanism of the 
NCS-1–induced activation of Akt, we next examined the effect 
of overexpression of NCS-1 and E120Q on the subcellular 
  localization of Akt/PKB in living cells. Akt/PKB is known to 
be translocated to the plasma membrane when it is fully acti-
vated  upon phosphorylation and bound with its substrates 
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 (Alessi et al., 1996). We con-
structed the GFP-tagged pleckstrin homology (PH) domain of 
Akt/PKBα (EGFP-Akt/PKB-PH) and transiently cotransfected 
it into CCL39 cells, which express a small amount of endoge-
nous NCS-1, together with NCS-1, E120Q, or empty vector. 2 d 
later, the subcellular localization of EGFP-tagged Akt/PKB-PH 
was assessed on a confocal microscope. Akt/PKB-PH was dif-
fusely localized in the cytosol of vector-transfected control cells 
(Fig. 5 E). Interestingly, Akt/PKB-PH became localized in the 
peripheral region of cells when NCS-1 was coexpressed, but 
this peripheral localization was abolished when E120Q was 
  coexpressed (Fig. 5 E). Qualitatively similar results were also 
  obtained when primary cultured cortical neurons were treated 
with the same vectors; i.e., Akt/PKB-PH was localized in the 
peripheral regions of neurons when NCS-1 was overexpressed, 
but a more diffuse localization pattern was observed when 
E120Q was overexpressed (Fig. 5 F). The distribution pattern 
of Akt/PKB-PH in vector-transfected neurons was similar to 
that of NCS-1–overexpressing cells (not depicted). These  results 
strongly demonstrate that NCS-1 increases the levels of plasma 
membrane PtdIns(3,4)P2 and PtdIns(3,4,5)P3 and, thus, acti-
vates Akt/PKB in living cells.
Dominant-negative NCS-1 accelerates 
the in vivo axotomy-induced loss of neurons
We examined the effects of the overexpression of NCS-1 and its 
dominant-negative mutant on the survival of these neurons to 
clarify the physiological role of NCS-1 in injured motor  neurons 
in vivo. One side of vagus nerves of adult rats were axotomized 
as previously described (Fig. 1) and infected with adenoviral 
vectors encoding NCS-1, E120Q, or EGFP vector alone, and 
neuronal degeneration was evaluated by histological analysis. 
1 wk after axotomy, nearly 30% of nerve cells were found to be 
EGFP positive in the injured side (Fig. 6 A).  [ID]FIG6[/ID] There were clear 
differences in the staining pattern between control and injured 
sides for all groups, probably because the regeneration process, 
such as activation of the surrounding glial cells, was ongoing on 
injured sides. However, the number of surviving motor neurons 
stained with hematoxylin were not signifi  cantly decreased at the 
injured side for vector-treated DMV sections (Fig. 6, B and D; 
examples of counted neurons are indicated by black arrows 
in C). This would probably be the result of natural antiapoptotic 
mechanisms induced by injury, which exist in mature neurons 
as previously reported (Benn and Woolf, 2004). Because the 
  expression level of NCS-1 was signifi   cantly increased in 
  response to in vivo axotomy (Fig. 1), we hypothesized that 
NCS-1 may be involved in this antiapoptotic mechanism. If so, 
blocking of endogenous NCS-1 would reduce this benefi  cial 
  effect. As expected, the dominant-negative E120Q mutant 
  resulted in a signifi  cant loss of neurons in the injured side (Fig. 6, 
B–D), and some TUNEL-positive nuclei were also detected 
only in this group (Fig. 6 E, arrows; and its magnifi  ed image 
in F). Considering that the infection effi  ciency was only  30% 
in these experiments, a large majority of neurons successfully 
  infected with E120Q appear to have undergone apoptosis. 
  Infection of neurons with the functional NCS-1 adenovirus only 
had a modest effect on neuronal survival. This probably results 
from both the low infection effi  ciency and the high levels of 
  endogenous NCS-1 expression in axotomized neurons (Fig. 1) 
because the NCS-1 effects are already close to maximum. Thus, 
the dominant-negative mutant E120Q inhibited the survival 
of adult DMV neurons from axotomy-induced injury, strongly 
suggesting that NCS-1 is one of the important factors mediating 
neuronal survival after in vivo axotomy.
Discussion
Numerous stressors, including physical or chemical injury 
and genetic abnormalities, lead to neuronal degeneration by 
 programmed cell death along an apoptotic pathway. Under these 
conditions, some intrinsic and extrinsic factors, including neu-
rotrophic factors, are known to activate the antiapoptotic  process 
to rescue neurons from death. However, the sig  naling pathway 
leading to cell survival is not yet completely understood.
In this study, we identifi  ed a novel function for the Ca
2+-
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of cultured neurons via PI3-K–Akt signaling pathways; (2) medi-
ates, at least in part, GDNF-induced neuroprotection; and (3) is 
up-regulated in response to axonal injury and plays an important 
role in the antiapoptotic mechanism in injured motor neurons.
NCS-1 is a novel survival-promoting factor 
in neuronal cells
We observed that the overexpression of NCS-1 rendered PC-12 
cells and primary cultured cortical neurons more tolerant to 
  several kinds of stressors, such as oxidative stress or trophic 
supplement withdrawal (Figs. 2 and 3), demonstrating that the 
expression of NCS-1 protects neurons from cell death under 
apoptotic conditions. In addition, overexpression of an EF-
hand dominant-negative mutant E120Q signifi  cantly acceler-
ated apoptosis when B27 trophic supplements were kept in the 
  culture medium (Fig. 3 D), suggesting that endogenous NCS-1 
is important for keeping the long-term survival of cultured 
  neurons under normal (or less apoptotic) conditions. The 
latter fi  nding also indicates that Ca
2+ binding is required for 
NCS-1–mediated cell survival. On the basis of these fi  ndings, 
we   propose that NCS-1 is a novel member of survival-promoting 
factors in cultured neurons.
NCS-1 mediates GDNF-induced cell 
survival via activation of the PI3-K–Akt 
survival pathway
We found that treatment of cultured cortical neurons with a 
  neurotrophic factor GDNF increased the expression level of 
NCS-1 (Fig. 4 C) and enhanced neuronal survival (Fig. 4, A and B), 
which is consistent with a previous study reporting that 
GDNF enhanced the expression of frequenin/NCS-1 in  Xenopus 
motor neurons (Wang et al., 2001). GDNF-induced increase 
in the NCS-1 level appeared to be caused by the synthesis of 
protein and/or mRNA but not by the prevention of NCS-1 
  degradation because GDNF did not raise the expression level 
of NCS-1 in the presence of the inhibitor of protein synthesis 
 cycloheximide  (10  μg/ml for 20 h; not depicted). In contrast 
to the vector-treated control neurons, GDNF did not further 
  enhance the   survival effect in neurons overexpressing NCS-1 
(Fig. 4, A and B), suggesting that cell viability was already 
 suffi  ciently high under this condition. Strikingly, the survival-
  promoting effect of GDNF was largely prevented by overexpres-
sion of the dominant-negative mutant E120Q (Fig. 4, A and B), 
  suggesting that NCS-1 mediates the GDNF survival signal.
GDNF activates at least two intracellular pathways in 
  neurons: one involving the PI3-K–Akt pathway and another 
  involving the MAPK (p42 and p44, also called ERK1 and 
ERK2) pathway. However, PI3-K but not the MAPK path-
way has been reported to be responsible for GDNF-mediated 
neuronal survival in motor neurons (Soler et al., 1999). 
In accordance with this study, we observed that exposure of 
primary cultured cortical neurons to GDNF resulted in a 
large increase in the phospho-Akt level (Fig. 5 A). In the 
same way, the overexpression of NCS-1 also dramatically 
enhanced the phosphorylation levels of Akt both in the 
  presence and absence of B27 trophic supplements, whereas 
the overexpression of dominant-negative mutant E120Q did 
not (Fig. 5 A). In addition, the NCS-1–  nduced survival-
 promoting  effect was largely inhibited by the PI3-K   inhibitor 
LY294002 but not the MEK inhibitor PD98059 (Fig. 5, C 
and D). Furthermore, NCS-1 increased the plasma membrane 
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 levels, which indicates the 
activation of Akt in intact cells (Fig. 5, E and F). These 
  results strongly suggest that NCS-1 is a novel downstream 
target that mediates GDNF survival signal through activation 
of the PI3-K–Akt pathway.
Figure 6.  Dominant-negative NCS-1 mutant E120Q promotes the axotomy-
  induced degeneration of DMV neurons. After the axotomy of vagus motor 
  neurons were performed as described in Fig.1, adenoviral vectors carry-
ing NCS-1, E120Q, or EGFP alone were injected from the stump of the 
nerve. 1 wk after the treatment, the brainstem was excised, and serial sec-
tions were cut. (A) Representative EGFP ﬂ  uorescence image showing that 
EGFP signals were detected in some cells on the injured side. Positions of 
DMV neurons are indicated by circles in A, B, and E. (B) Histological evalu-
ation of DMV neurons in adenovirus-treated animals by hematoxylin/eosin 
staining. (C) Magniﬁ  ed image of the boxed area in B for E120Q-treated 
DMV neurons. Only neurons (indicated by black arrows), not   nuclei, of 
glial or endothelial cells (indicated by red arrows) were counted. (D) Sum-
marized data obtained from B. *, P < 0.05 versus the control side of the 
same section. #, P < 0.05 versus the injured side of vector-treated ani-
mals (means ± SEM [error bars]; n = 6 from three animals). (E) An exam-
ple of the TUNEL-staining pattern obtained from an E120Q-treated animal. 
(F) The magniﬁ  ed image of the boxed area in E.   TUNEL-positive nuclei are 
indicated by arrows. Bar (B), 100 μm; (F) 25 μm.JCB • VOLUME 172 • NUMBER 7 • 2006  1088
Possible mechanisms of the action of NCS-1
Several possible mechanisms may underlie the survival 
action of NCS-1. We observed that Akt/PKB-PH was recruited 
to the plasma membrane when NCS-1 was coexpressed, 
  suggesting that NCS-1 acts upstream of the Akt pathway. 
NCS-1 was previously reported to activate PI4-K (Hendricks 
et al., 1999), which increases the level of plasma membrane 
PtdIns(4)P, the   substrate of PI3-K, as well as PI5-K. There-
fore, upon activation of these kinases, other phosphoinosi-
tides would be produced. Indeed, it has been reported that 
the overexpression of NCS-1 signifi   cantly increased both 
PtdIns(4)P and PtdIns(4,5)P2 levels in PC-12 cells (Koizumi 
et al., 2002). Furthermore, PtdIns(3,4)P2 and PtdIns(3,4,5)P3, 
the substrates of Akt/PKB, would also be   produced, which, 
in turn, would activate the Akt pathway (Cantley, 2002). 
As expected, the overexpression of NCS-1   increased the 
plasma membrane PtdIns(3,4)P2 and PtdIns(3,4,5)P3 levels 
both in CCL39 cells and neuronal cells (Fig. 5, E and F), en-
hanced the phosphorylation of Akt (Fig. 5 A), and promoted 
neuronal survival (Fig. 3). Therefore, we propose that activa-
tion of such a phosphatidylinositol pathway is a mechanism 
for the survival action of NCS-1. In addition, we observed that 
in contrast to GDNF, our preliminary data show that BDNF 
did not increase the expression level of NCS-1   (unpublished 
data) despite the reported survival-  promoting   effect of BDNF 
in cultured cortical neurons (Cheng et al., 2003). Interestingly, 
BDNF-induced survival signaling has been reported to be 
  mediated by CaM, another Ca
2+-binding protein in   cortical 
neurons (Cheng et al., 2003), and CaM has been   reported to 
directly activate PI3-K (Perez-Garcia et al., 2004).   Therefore, 
NCS-1 mediates the GDNF signal by activating PI4-K, whereas 
CaM mediates the BDNF signal by activating PI3-K. These two 
  signals would lead the survival signal to the Akt pathway.
On the other hand, it is also possible that NCS-1 promotes 
neuronal survival by some other mechanisms in addition to 
 activation of the Akt pathway. For example, the survival- promoting 
effect of NCS-1 appears to be analogous to that of the recently 
characterized antiapoptotic protein family called inhibitors of 
apoptosis, which suppress apoptosis through the direct inhibition 
of caspases (Liston et al., 2003). Some of these proteins, such as 
neuronal apoptosis inhibitory protein and X-linked inhibitors of 
apoptosis protein, have been reported to be essential for GDNF-
mediated neuroprotective effects in injured motor neurons in vivo 
(Perrelet et al., 2002). Furthermore, recent evidence demon-
strates that neuronal apoptosis inhibitory protein interacts with 
hippocalcin, another closely related Ca
2+-binding protein that 
affects   caspase-12 activity (Korhonen et al., 2005) and protects 
neurons against Ca
2+-induced cell death (Mercer et al., 2000). 
Therefore, we do not exclude the possi bility that like these proteins, 
NCS-1 also   exerts a more direct   effect on some caspases. We are 
currently   investigating the   possible interaction of these proteins.
As NCS-1 is known to interact with voltage-gated K
+ 
channels (Kv4; Nakamura et al., 2001), it might also increase 
the resistance of neurons to excitotoxic apoptosis through the 
activation of K
+ channels. Increased outward K
+ current would 
prevent neurons from reaching fi  ring threshold and, thereby, 
prevent cells from Ca
2+ overload leading to cell death.
NCS-1 is a novel survival-promoting factor 
up-regulated in injured neurons
In this study, we found that the expression level of NCS-1 was 
signifi  cantly increased in response to axonal injuries (tran-
section of the vagus nerve as well as treatment of nerves with 
  colchicine) in the DMV neurons of adult rats (Fig. 1). The 
  behavior of NCS-1 appears to be analogous to that of the 
 recently  identifi  ed protein damage-induced neuronal endopep-
tidase, which is expressed in response to neuronal damages 
  induced by nerve transection and colchicine treatment in both 
the central and peripheral nervous systems (Kiryu-Seo et al., 
2000).   Because antiapoptotic mechanisms are activated in 
  mature neurons in response to stress to protect against acciden-
tal apoptotic cell death, it has been described that peripheral 
axotomy in adult neurons does not result in extensive cell death 
(Benn and Woolf, 2004). In accordance with this, we also 
  observed that little loss of motor neurons was evident by in vivo 
axotomy in vector-treated control neurons (Fig. 6, B and D). 
The expression of exogenous NCS-1 did not exert the further 
benefi  cial effect (Fig. 6, B and D). This marginal effect of exog-
enous NCS-1 (compared with the vector control group) would 
be the result of the increased expression level of endogenous 
NCS-1 in axotomized neurons, which occurs for all groups. 
In contrast, overexpression of dominant-negative E120Q sig-
nifi  cantly decreased the number of surviving neurons (Fig. 6, 
B–D) and produced TUNEL-positive apoptotic neurons at the 
injured side (Fig. 6, E and F), indicating that disruption of 
NCS-1 function increased the vulnerability of DMV neurons 
to axotomy.
Overexpression of NCS-1 rendered PC-12 cells resistant 
to H2O2 toxicity even in the absence of GDNF (Fig. 2), suggest-
ing that NCS-1 itself is enough to promote cell survival. This is 
consistent with our view that NCS-1 is the downstream target 
for GDNF. Because growing evidence indicates that nerve 
  injury leads to the up-regulation of multiple antiapoptotic mole-
cules, including GDNF (Liberatore et al., 1997; Yamamoto et al., 
1998; Wang et al., 2002), it is possible that neuronal damages 
induced by in vivo axotomy enhance the synthesis and/or secre-
tion of GDNF, which, in turn, up-regulates NCS-1 expression 
and promotes neuronal survival in injured neurons. Although an 
underlying mechanism would be different, the up-regulation of 
NCS-1 has also been reported in the cortex of schizophrenic and 
bipolar patients, demonstrating the involvement of NCS-1 in 
neurological disease (Koh et al., 2003).
In conclusion, we characterized a novel function of NCS-1 
mediating a GDNF-induced neuroprotective effect via activa-
tions of Akt kinase. Furthermore, we found that NCS-1 is 
up-regulated in response to nerve injury and plays an important 
role in the antiapoptotic mechanism in adult motor neurons. 
Our present fi  ndings would provide new and basic insights into 
the mechanism of neuronal regeneration.
Materials and methods
Plasmids and viral vectors
E120Q NCS-1 point mutant was generated with a conventional PCR 
  protocol using the wild-type rat NCS-1 (GenBank/EMBL/DDBJ accession 
no. <GENBANK>L27421 </GENBANK>) as a template and was sequenced to conﬁ  rm the mutation.ROLE OF NCS-1 AS A NEUROPROTECTIVE FACTOR • NAKAMURA ET AL. 1089
Akt/PKBα cDNA was cloned from the human kidney cDNA library 
(CLONTECH Laboratories, Inc.), and NH2-terminally tagged ﬂ  uorescent 
protein EGFP-Akt/PKB-PH was constructed incorporating a fragment of 
750 bp, encoding the ﬁ  rst 250 amino acids of PKBα (containing the PH 
domain) into EGFP-vector as described previously (Currie et al., 1999).
Adenovirus containing wild-type NCS-1 and the E120Q mutant 
  inserts were generated by cotransfecting either of these plasmids and 
pBHG11 (Microbix Biosystems, Inc.) into HEK 293 cells. Viral DNA was 
isolated from the supernatant in the wells displaying the cytopathic effect. 
Replication-incompetent virus containing DNA inserts were plaque-puriﬁ  ed 
twice and grown on HEK 293 cells to produce large amounts of adeno-
virus. Tissue culture supernatant containing adenovirus was concentrated 
by centrifugation over cesium chloride. The titers of viral stocks were 
2.2 × 10
10 pfu/ml for EGFP–NCS-1, 1.1 × 10
10 pfu/ml for EGFP-E120Q, 
and 2.2 × 10
10 pfu/ml for EGFP-vector.
Cell cultures
PC-12 cells stably transfected with vector alone or vector containing cDNA 
coding for the wild-type NCS-1 (several clones) were grown onto collagen-
coated (500 μg/ml of type I; Sigma-Aldrich) culture dishes in growth 
  medium (DME containing 10% horse serum, 5% FBS, and 400 μg/ml 
  geneticin and gentamicin) as described previously (Koizumi et al., 2002). 
When cells became 80% conﬂ  uent, they were switched to the differentiation 
medium (growth medium with half serum) supplemented with 100 ng/ml 
NGF-7S (Invitrogen).
Primary culture of cortical neurons was performed using the cortex 
from Sprague-Dawley rats at embryonic day 18. In brief, cortical tissues 
were isolated from whole brain, minced into small pieces, and digested for 
10 min at 37°C in a 20-U/ml papain solution containing 0.002% DNase I 
(Worthington Biochemical Corp.). After titration of the enzymatic activity, 
cells were mechanically dissociated by several passages through pipette 
tips. After centrifugation, cells were resuspended in neurobasal medium 
supplemented with B27 trophic factors (both from Invitrogen), whose com-
positions were reported previously (Brewer et al., 1993). They were then 
plated onto culture dishes coated with 0.1% polyethylenimine at a density 
of 2.5–5 × 10
4 cells/cm
2 for cell survival assay and 10
5 cells/cm
2 for 
  immunoblot analysis.
Fluorescent microscopy
CCL39 cells and primary cultured rat cortical neurons were plated onto 
collagen-coated glass coverslips and cultivated for 1 d. They were then 
transiently transfected with the EGFP-Akt/PKB-PH construct together with 
  either NCS-1, E120Q, or pCDNA3 (1:3 ratio) using LipofectAMINE 2000 
(Invitrogen) and were subjected to immunocytochemistry. In brief, cells 
were ﬁ   xed with 4% PFA, permeabilized with 0.2% Triton X-100, and 
blocked with 5% BSA. They were then incubated for 1 h with anti–NCS-1 
antibody (1:200) followed by incubation with secondary antibodies (FITC- 
or rhodamine-conjugated goat anti–rabbit IgG; 1:200; Jackson Immuno-
Research Laboratories). After extensive wash with PBS, cell images were 
scanned on a laser confocal microscope (MRC-1024K; Bio-Rad Labora-
tories) or obtained with conventional epiﬂ  uorescence illumination (BX50WI; 
Olympus) with a cooled CCD camera (CoolSNAP; Photometrics) using 
a 0.9-W 60× water immersion objective lens. Immunocytochemistry for 
PC-12 cells were also performed in the same way.
Evaluation of neuronal survival
The primary cultured neurons were infected with viruses at a multiplicity of 
infection of 100 pfu/cell at 5 d after plating. Under this condition, we found 
that nearly 70% of the neurons were infected by monitoring EGFP ﬂ  uores-
cence (Fig. 3 A). The number of living neurons was counted within the ﬁ  xed 
area of images taken by a digital camera (Coolpix 4500; Nikon). To count 
the number of cells always within the same area, a grid seal with numbering 
(Asahi Techno glass) was stuck on the bottom of each culture dish. The num-
ber of living neurons remaining at each day was expressed as a percentage 
of the initial number. Neurons showing the degenerating stage character-
ized by nuclear condensation, membrane blebbing, or extensive neurite 
fragmentation were excluded. Four different regions were selected from one 
dish, and six separate experiments were performed for each condition.
To identify and quantify apoptotic neurons, cells were ﬁ  xed with 4% 
PFA and were stained with Hoechst 33258. Coverslips were mounted onto 
glass slides, and cells were observed under epiﬂ  uorescence illumination on 
an inverted microscope (1X71; Olympus) using a 40× NA 1.35 oil immer-
sion objective lens (Olympus). Cells were considered apoptotic if their nuclear 
chromatin was condensed or fragmented, whereas cells were considered 
  viable if their chromatin was diffusely and evenly distributed throughout the 
nucleus (Fig. 3 F).
Immunoblot analysis
DMV tissue samples were obtained by scratching the DMV neurons from 
several frozen sections of brainstem (described in the next section) using 
pulled glass capillary under the light microscope. These tissue samples or 
cultured cells (PC-12 cells and cortical neurons) were then solubilized in 
SDS-PAGE sample buffer containing protease and phosphatase inhibitors 
and subjected to immunoblot analysis using image density software (Scion 
Image; Scion Corp.) as previously described (Nakamura et al., 2001). 
  Primary antibodies used were anti–NCS-1 antibody (1:1,000), which 
was previously described (Jeromin et al., 1999), and publicly available 
antibodies: monoclonal anti-GAPDH antibody (1:1,000) obtained from 
Chemicon as well as antiphospho-Akt antibodies (detectable for the phos-
phorylation of Thr308 and Ser473; 1:1,000) and anti-Akt antibody 
(1:1,000; both from Cell Signaling Technology). Secondary antibodies 
used were HRP-conjugated anti–rabbit and anti–mouse antibodies or a 
combination of biotinylated anti–rabbit (or mouse) antibodies (Zymed 
  Laboratories) and HRP-conjugated streptavidin (Zymed Laboratories).
In vivo axotomy and colchicine treatment
The method of vagus axotomy was described previously (Nabekura et al., 
2002a). In brief, 4–6-wk-old Sprague-Dawley rats were deeply anesthe-
tized with 50 mg/kg pentobarbital, and axotomy of the vagus motor 
  neurons was performed with ﬁ  ne scissors at the unilateral vagus nerve at 
the neck. Injured neurons were conﬁ  rmed by detecting the ﬂ  uorescence 
of Di-I in the DMV, which had been placed at the proximal cut site of the 
nerve bundle (Nabekura et al., 2002a).
To test the effects of colchicine, an implantable polymer containing 
10% (wt/vol) colchicine was made by mixing colchicine with ethylene-vinyl 
acetate copolymer (Elvax) followed by drying as described previously 
(Kakizawa et al., 2000). Solid slices ( 1 mm
2) were placed around the 
unilateral vagal nerve to allow the continuous release of colchicine from 
slices. The skin incision was closed, and rats were returned to the cage 
 after awaking from the anesthetic.
Histology
1 d to 2 mo (usually 1 wk) after receiving ipsilateral vagal axotomy, brain-
stems were quickly removed, and 8–10-μm-thick frozen sections were cut. 
Immunohistochemistry was performed using the labeled biotin–streptavidin 
method. In brief, after ﬁ  xation and blocking, the sections were incubated 
at 4°C overnight with a rabbit polyclonal antibody against NCS-1 at a dilution 
of 1:15,000 and were sequentially incubated with a biotinylated anti–rabbit 
secondary antibody and a HRP-conjugated streptavidin–biotin complex
(GE Healthcare). The colored reaction product was developed with DAB 
solution. The sections were lightly counterstained with hematoxylin to visualize 
nuclei. Images were acquired using a digital camera (FX380; Olympus) 
equipped with an image ﬁ  ling software (FLVFS-LS; Flovel).
Comparison of the expression level of NCS-1 between injured and 
control sides were performed using computerized image analysis (Win 
Roof; Mitani Corp.). In brief, the DMV region from the injured side was at 
ﬁ  rst selected, and the image was converted to binary images by thresholding 
so that only the area highly stained with anti–NCS-1 antibody could be 
  detected. The same threshold level was used for both the control and 
  injured DMV in each tissue section. The highly stained area was summated 
and represented as normalized values.
Neuronal degeneration was evaluated by counting surviving   neurons 
as described previously (Rothstein et al., 2005) as well as by   TUNEL staining 
using the apoptag peroxidase in situ Apoptosis Detection Kit (Chemicon). 
In brief, in vivo axotomy was performed as described above, and, at the 
same time, adenoviral vectors carrying EGFP only, EGFP plus NCS-1, 
or E120Q (10
9 pfu each) was injected into the stump of the nerve using a 
34-gauge needle. 1 wk after axotomy, parafﬁ  n-embedded serial sections 
(3–4 μm) were made from the brainstem. After they were deparafﬁ  nized, 
sections were directly stained with hematoxylin/  eosin to visualize the struc-
ture of the DMV region. TUNEL staining was   performed in accordance with 
the manufacturer’s method. The sections were lightly counterstained with 
methyl green. Control sections were treated similarly but incubated in the 
absence of TdT enzyme. To conﬁ  rm whether the adenoviral vectors were 
transferred to the DMV neurons,   another set of animals were treated in the 
same way. 8-μm frozen sections were cut 1 wk after operation, and EGFP 
signals were viewed under a ﬂ  uorescence   microscope (1X71; Olympus). 
All image acquisitions were performed at room temperature, and images 
were subsequently processed using Adobe Photoshop (version 7) and 
Adobe Illustrator (version 10) software. All   experiments conformed to the 
Guiding Principles for the Care and Use of Animals approved by the Council 
of the Physiological Society of Japan. All efforts were made to minimize 
the number of animals used and their suffering.JCB • VOLUME 172 • NUMBER 7 • 2006  1090
Statistics
Comparisons between two groups were performed using the paired or 
  unpaired t test. Values of P < 0.05 were considered statistically signiﬁ  cant. 
All summarized data are expressed as means ± SEM.
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